Idorsia Ltd (IDRSF)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -254.55 Million CHF | 33.08% |
| 2022 | -783.08 Million CHF | -32.99% |
| 2021 | -588.83 Million CHF | -39.99% |
| 2020 | -420.63 Million CHF | 9.1% |
| 2019 | -456.94 Million CHF | -31.64% |
| 2018 | -351.51 Million CHF | -16306.22% |
| 2017 | 2.16 Million CHF | 100.71% |
| 2016 | -305.19 Million CHF | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -90.77 Million CHF | 18.78% |
| 2024 Q2 | -92.83 Million CHF | -10.96% |
| 2023 Q1 | -201.81 Million CHF | -12.47% |
| 2023 Q3 | 237.42 Million CHF | 229.98% |
| 2023 Q2 | -182.65 Million CHF | 9.49% |
| 2023 FY | - CHF | 33.08% |
| 2023 Q4 | -110.65 Million CHF | -146.61% |
| 2022 FY | - CHF | -32.99% |
| 2022 Q4 | -179.44 Million CHF | 7.54% |
| 2022 Q3 | -194.08 Million CHF | 8.25% |
| 2022 Q2 | -211.52 Million CHF | -13.1% |
| 2022 Q1 | -187.01 Million CHF | 18.78% |
| 2021 Q3 | -129.13 Million CHF | 2.26% |
| 2021 Q1 | -97.32 Million CHF | 27.61% |
| 2021 Q2 | -132.12 Million CHF | -35.75% |
| 2021 FY | - CHF | -39.99% |
| 2021 Q4 | -230.25 Million CHF | -78.31% |
| 2020 Q4 | -134.45 Million CHF | -19.66% |
| 2020 Q2 | -62.11 Million CHF | 44.39% |
| 2020 Q1 | -111.69 Million CHF | 16.87% |
| 2020 Q3 | -112.36 Million CHF | -80.9% |
| 2020 FY | - CHF | 9.1% |
| 2019 Q2 | -115.65 Million CHF | -1.55% |
| 2019 FY | - CHF | -31.64% |
| 2019 Q4 | -134.36 Million CHF | -35.98% |
| 2019 Q3 | -98.81 Million CHF | 14.57% |
| 2019 Q1 | -113.89 Million CHF | -20.8% |
| 2018 Q3 | -111.2 Million CHF | -49.01% |
| 2018 FY | - CHF | -16306.22% |
| 2018 Q4 | -94.28 Million CHF | 15.21% |
| 2018 Q2 | -74.62 Million CHF | -4.53% |
| 2018 Q1 | -71.39 Million CHF | -192.52% |
| 2017 Q2 | 100.92 Million CHF | 194.47% |
| 2017 Q3 | -64.46 Million CHF | -163.88% |
| 2017 Q4 | 77.16 Million CHF | 219.7% |
| 2017 Q1 | -106.83 Million CHF | 0.0% |
| 2017 FY | - CHF | 100.71% |
| 2016 FY | - CHF | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.06 Million USD | -8210.469% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -7076.519% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -11042.579% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -1365.463% |
| GB Sciences, Inc. | -1.41 Million USD | -17827.579% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 67291.509% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -2081435.694% |
| Skye Bioscience, Inc. | -13.54 Million USD | -1778.945% |
| Zenith Capital Corp. | -8.6 Million USD | -2857.832% |
| Agentix Corp. | -1.37 Million USD | -18456.58% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -6453.296% |
| Biomind Labs Inc. | -1.03 Million USD | -24505.021% |
| ContraFect Corporation | -64.99 Million USD | -291.623% |
| CSL Limited | 4.78 Billion USD | 105.315% |
| CytoDyn Inc. | -18.02 Million USD | -1311.897% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 3785807.912% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -40151.199% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -359.985% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -69218.203% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -16471.802% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -27068.074% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 370.689% |
| SQZ Biotechnologies Company | -64.14 Million USD | -296.862% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -17013.685% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -258.341% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -9525.865% |
| Mesoblast Limited | -62.38 Million USD | -308.001% |
| Marizyme, Inc. | -34.28 Million USD | -642.532% |
| Genus plc | 73.7 Million USD | 445.388% |
| Pharming Group N.V. | 9.87 Million USD | 2677.21% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -2801.858% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -18058.764% |
| IMV Inc. | -35.52 Million USD | -616.573% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -10853.99% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -49036.756% |
| ONE Bio Corp. | 13.61 Million USD | 1969.905% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -427.818% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 7226.288% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -8700.91% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -3454.549% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -1018104.0% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -1504.003% |
| Alpha Cognition Inc. | -9.7 Million USD | -2522.723% |
| Enzolytics Inc. | -2.12 Million USD | -11895.642% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -216.02 Million USD | -17.835% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 21016.27% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 2975.048% |
| Genscript Biotech Corporation | -248.71 Million USD | -2.345% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -4193.387% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -106339.891% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -10304.866% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -144511.234% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -13151.577% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -3750.115% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -5523.951% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -6694.515% |
| Helix BioMedix, Inc. | -1.04 Million USD | -24228.403% |
| EV Biologics, Inc. | -1.26 Million USD | -19988.752% |
| Q BioMed Inc. | -617.62 Thousand USD | -41114.291% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -14445.78% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -542.208% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.55 Million USD | -3269.909% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -10074.055% |
| HST Global, Inc. | -5303.00 USD | -4800032.001% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -12274.866% |
| Halberd Corporation | -74.27 Thousand USD | -342595.782% |
| Resverlogix Corp. | -11.74 Million USD | -2067.867% |
| Cell Source, Inc. | -4.27 Million USD | -5857.857% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -16882.453% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -6.11 Million USD | -4064.336% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -1461073.297% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -1.03 Million USD | -24499.124% |
| Kadimastem Ltd | -2.62 Million USD | -9599.468% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -66954.159% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -140467.569% |
| LadRx Corporation | 412.28 Thousand USD | 61841.813% |
| Regen BioPharma, Inc. | 1.46 Million USD | 17464.164% |
| Affymax, Inc. | -14.29 Million USD | -1680.7% |
| Itoco Inc. | -1.86 Million USD | -13519.673% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -22709.229% |
| Mobile Lads Corp. | -2.24 Million USD | -11258.007% |
| International Stem Cell Corporation | 202 Thousand USD | 126115.347% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -3.82 Million USD | -6563.382% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -321998.217% |
| Qrons Inc. | -40.08 Thousand USD | -634991.44% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -52311.474% |
| SYBLEU INC | -141.57 Thousand USD | -179704.48% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 48362.244% |
| Rebus Holdings, Inc. | -951 Thousand USD | -26666.667% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -23868.795% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -483469.529% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -10239.481% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -609.669% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -565568.889% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -9196.969% |
| Neutra Corp. | -181.24 Thousand USD | -140344.256% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1162.716% |
| PureTech Health plc | -11.62 Million USD | -2089.309% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -1162.803% |
| IXICO plc | -707 Thousand USD | -35904.385% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -3212.31% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -426.519% |
| CSL Limited | 4.73 Billion USD | 105.378% |
| Cellectis S.A. | -92.63 Million USD | -174.786% |